Literature DB >> 26414684

How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?

Charles R M Bangham1, Lee Ratner2.   

Abstract

A typical person infected with the retrovirus human T-lymphotropic virus type 1 (HTLV-1) carries tens of thousands of clones of HTLV-1-infected T lymphocytes, each clone distinguished by a unique integration site of the provirus in the host genome. However, only 5% of infected people develop the malignant disease adult T cell leukaemia/lymphoma, usually more than 50 years after becoming infected. We review the host and viral factors that cause this aggressive disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26414684      PMCID： PMC4772697          DOI： 10.1016/j.coviro.2015.09.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN： 1879-6257            Impact factor:   7.090


  84 in total

Review 1.  Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.

Authors:  Charles R M Bangham; Frédéric Toulza
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

2.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Pathological features of diseases associated with human T-cell leukemia virus type I.

Authors:  Koichi Ohshima
Journal:  Cancer Sci       Date:  2007-03-27       Impact factor: 6.716

4.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.

Authors:  K Tsukasaki; H Tsushima; M Yamamura; T Hata; K Murata; T Maeda; S Atogami; H Sohda; S Momita; S Ideda; S Katamine; Y Yamada; S Kamihira; M Tomonaga
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

5.  In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Authors:  Becca Asquith; Yan Zhang; Angelina J Mosley; Catherine M de Lara; Diana L Wallace; Andrew Worth; Lambrini Kaftantzi; Kiran Meekings; George E Griffin; Yuetsu Tanaka; David F Tough; Peter C Beverley; Graham P Taylor; Derek C Macallan; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

6.  Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.

Authors:  Mineki Saito; Veronique M Braud; Peter Goon; Emmanuel Hanon; Graham P Taylor; Akiko Saito; Nobutaka Eiraku; Yuetsu Tanaka; Koichiro Usuku; Jonathan N Weber; Mitsuhiro Osame; Charles R M Bangham
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

Review 7.  Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.

Authors:  Kathryn S Jones; Sophie Lambert; Manuella Bouttier; Laurence Bénit; Frank W Ruscetti; Olivier Hermine; Claudine Pique
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

8.  A transgenic mouse model of human T cell leukemia virus type 1-associated diseases.

Authors:  Takeo Ohsugi
Journal:  Front Microbiol       Date:  2013-03-08       Impact factor: 5.640

9.  HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase.

Authors:  Sarah S Durkin; Xin Guo; Kimberly A Fryrear; Valia T Mihaylova; Saurabh K Gupta; S Mehdi Belgnaoui; Abdelali Haoudi; Gary M Kupfer; O John Semmes
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).

Authors:  Anne-Sophie Kuhlmann; Julien Villaudy; Louis Gazzolo; Marc Castellazzi; Jean-Michel Mesnard; Madeleine Duc Dodon
Journal:  Retrovirology       Date:  2007-12-13       Impact factor: 4.602
View more
  31 in total

Review 1.  More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Authors:  Marta M Gaglia; Karl Munger
Journal:  Curr Opin Virol       Date:  2018-09-27       Impact factor: 7.090

2.  The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability.

Authors:  Aditi Malu; Tetiana Hutchison; Laçin Yapindi; Katie Smith; Katherine Nelson; Rachel Bergeson; Jordan Pope; Megan Romeo; Carolyn Harrod; Lee Ratner; Carine Van Lint; Robert Harrod
Journal:  Virology       Date:  2019-07-03       Impact factor: 3.616

3.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

4.  The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.

Authors:  Megan Romeo; Tetiana Hutchison; Aditi Malu; Averi White; Janice Kim; Rachel Gardner; Katie Smith; Katherine Nelson; Rachel Bergeson; Ryan McKee; Carolyn Harrod; Lee Ratner; Bernhard Lüscher; Ernest Martinez; Robert Harrod
Journal:  Virology       Date:  2018-02-20       Impact factor: 3.616

5.  Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice.

Authors:  Devra D Huey; Brad Bolon; Krista M D La Perle; Priya Kannian; Steven Jacobson; Lee Ratner; Patrick L Green; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

6.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

7.  Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.

Authors:  Jolynn Zu Lin Ong; Rui Yokomori; Regina Wan Ju Wong; Tze King Tan; Ryuzo Ueda; Takashi Ishida; Shinsuke Iida; Takaomi Sanda
Journal:  Leukemia       Date:  2022-07-30       Impact factor: 12.883

8.  Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.

Authors:  Tatsuro Jo; Ritsuko Kubota-Koketsu; Yohei Kaneko; Takahiro Sakai; Kazuhiro Noguchi; Sadaharu Irie; Masatoshi Matsuo; Jun Taguchi; Kuniko Abe; Kazuto Shigematsu
Journal:  Cancer Immunol Immunother       Date:  2022-10-01       Impact factor: 6.630

Review 9.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

Review 10.  Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.

Authors:  Adrienne A Phillips; Janine C K Harewood
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 4.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.